Antigen-specific T cell activation and proliferation during oral tolerance induction

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 5868-5875

  Sun, Jiaren ^a   Dirden Kramer, Bernadette ^a   Ito, Komei ^a   Ernst, Peter B ^a,b   Van Houten, Nancy ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; OVALBUMIN; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONAL ANERGY; CYTOKINE RELEASE; DOWN REGULATION; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ANIMALS; CLONAL ANERGY; CYTOKINES; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; OVALBUMIN; T-LYMPHOCYTES;

EID: 0033563273     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kearney, E. R., K. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
2. Van Houten, N., and S. F. Blake. 1996. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 157:1337.
3. Haskins, K., R. Kubo, J. White, M. Pigeon, J. W. Kappler, and P. Marrack. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. J. Exp. Med. 157:1149.
4. +lo thymocytes in vivo. Science 250:1720.
5. + T cells. J. Exp. Med. 186:239.
6. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.
7. Van Houten, N., S. F. Blake, E. J. Li, T. A. Hallam, D. G. Chilton, W. K. Gourley, L. H. Boise, C. B. Thompson, and E. B. Thompson. 1997. Elevated expression of Bcl-2 and Bcl-x by intestinal intraepithelial lymphocytes: resistance to apoptosis by glucocorticoids and irradiation. Int. Immunol. 9:945.
8. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160:4719.
9. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
10. Krummel, M. F., T. J. Sullivan, and J. P. Allison. 1996. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immunol. 8:519.
11. Waterhouse, P., J. M. Penninger, A. Timms, A. Wakeham, K. P. Shahinian, K. P. Lee, H. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferation disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
12. Leach, D. R., M. F. Krummel, and J. P. Allison. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
13. Waterhouse, P., G. S. Duncan, T. W. Mak, G.-S. Feng, and T. W. Mak. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272:1179.
14. Sprent, J. 1995. Central tolerance of T cells. Int. Rev. Immunol. 13:95.
15. Gütgemann, I., A. M. Fahrer, J. D. Altman, M. M. Davis, and Y. Chien. 1998. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8:667.
16. Dianzani, U., M. Luqman, J. Rojo, J. Yagi, J. L. Baron, A. Woods, C. A. J. Janeway, and K. Bottomly. 1990. Molecular associations on the T cell surface correlate with immunological memory. Eur. J. Immunol. 20:2249.
17. lo cells are memory cells. Cell. Immunol. 130:459.
18. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
19. Gonnella, P. A., Y. Chen, J. Inobe, Y. Komagata, M. Quartulli, and H. L. Weiner. 1998. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J. Immunol. 160:4708.
20. Peng, H.-J., M. W. Turner, and S. Strobel. 1990. The generation of a "tolerogen" after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin. Exp. Immunol. 81:510.
21. + T cells. J. Exp. Med. 185:2133.
22. Ridge, J. P., E. J. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723.
23. Viney, J. L., A. M. Mowat, J. M. Omalley, E. Williamson, and N. A. Fanger. 1998. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160:5815.
24. Garside, P., E. Ingulli, R. Merica, J. G. Johnson, R. J. Noelle, and M. K. Jenkins. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281:96.
25. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
26. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
27. Thompson, C. B., and J. P. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445.
28. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
29. Samoilova, E. B., J. L. Horton, H. D. Zhang, S. J. Khoury, H. L. Weiner, and Y. H. Chen. 1998. CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 10:491.
30. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
31. Rott, O., B. Fleischer, and E. Cash. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434.
32. Berg, D. J., M. W. Leach, R. Kuhn, K. Rajewsky, W. Muller, N. J. Davidson, and D. Rennick. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:99.
33. Hagenbaugh, A., S. Sharma, S. M. Dubinett, S. Y. Wei, R. Aranda, H. Cheroutre, D. J. Fowell, S. Binder, B. Tsao, R. M. Locksley, et al. 1997. Altered immune responses in interleukin 10 transgenic mice. J. Exp. Med. 185:2101.
34. Singh, R. R., B. H. Hahn, and E. E. Sercarz. 1996. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J. Exp. Med. 183:1613.
35. Chen, Y., J. Inobe, and H. L. Weiner. 1997. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell. Immunol. 178:62.
36. Aroeira, L. S., F. Cardillo, D. A. Dealbuquerque, N. M. Vaz, and J. Mengel. 1995. Anti-IL-10 treatment does not block either the induction or the maintenance of orally induced tolerance to ova. Scand. J. Immunol 41:319.
37. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, and D. H. Hsu. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890.
38. Defrance, T., B. Vanbervliet, F. Briere, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:671.
39. Weiner, H. L., G. A. Mackin, M. Matsui, E. J. Orav, S. J. Khoury, D. M. Dawson, and D. A. Hafler. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321.
40. Trentham, D. E., R. A. Dynesius-Trentham, E. J. Orav, D. Combitchi, C. Lorenzo, K. L. Sewell, D. A. Hafler, and H. L. Weiner. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727.
41. Khare, S. D., C. J. Krco, M. M. Griffiths, H. S. Luthra, and C. S. David. 1995. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J. Immunol. 155:3653.
42. Muir, A., D. Schatz, and N. Maclaren. 1993. Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes. Diabetes Metab. Rev. 9:279.